Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 2 75 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 2 75 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER vs PERIKABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Parenteral nutrition providing amino acids for protein synthesis and dextrose for caloric support, bypassing gastrointestinal tract.
Perikabiven provides a balanced mixture of amino acids, electrolytes, dextrose, and lipids for parenteral nutrition. Amino acids serve as building blocks for protein synthesis, dextrose provides glucose for energy, and lipids supply essential fatty acids and a concentrated energy source. Electrolytes maintain osmotic balance and support biochemical reactions.
Intravenous administration of 2.75% amino acids and 10% dextrose at a rate to provide 1-2 g protein/kg/day and 5-25 g dextrose/kg/day based on metabolic needs. Infusion rate not to exceed 0.5 g dextrose/kg/hour initially.
Intravenous administration: usual adult dose is 1.5 to 2.0 g amino acids per kg per day, corresponding to 25-30 mL/kg/day of Perikabiven, with a maximum infusion rate of 2.5 mL/kg/hour.
None Documented
None Documented
Not applicable; components are endogenously regulated (amino acids: minutes to hours; dextrose: ~1-2 hours). For continuous infusion, steady-state achieved within 4-6 hours.
Amino acids: ~0.5-1 hour (rapid clearance due to metabolic incorporation and urinary elimination). Lipids: terminal elimination half-life of ~30 minutes to 1.5 hours for triglycerides, with longer half-life for essential fatty acids (days to weeks due to incorporation into cell membranes). Clinical context: rapid clearance from plasma with continuous infusion.
Renal: ~50% as unchanged amino acids and dextrose metabolites within 6 hours; remainder metabolized to CO2 and H2O, eliminated via lungs and urine.
Renal (primarily as ammonium and urea) and biliary (fecal loss of unabsorbed lipids). The amino acids, dextrose, and electrolytes are eliminated via renal excretion; lipids are metabolized and eliminated as CO2 and water. Approximately 20-30% of the lipid dose is excreted renally as metabolites, with <5% excreted unchanged.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition